EFM
CGON icon

E Fund Management’s CG Oncology CGON Stock Holding History

E Fund Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526K Sell
7,400
-1,379
-16% -$90.1K 0.01% 254
2026
Q1 		$594K Buy
+8,779
New +$497K 0.02% 251
2025
Q2 		$232K Buy
+8,932
New +$215K 0.01% 345

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

E Fund Management's CGON Position: Q2 2026 in Review

E Fund Management reduced its CG Oncology (CGON) stake by 16% in Q2 2026, selling an estimated $90.1K and leaving 7,400 shares worth $526K. The position accounts for 0.01% of the portfolio, ranked #254.

E Fund Management first reported a position in CGON in Q2 2025 and has held it in 3 quarters since. The position peaked at $594K in Q1 2026. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • E Fund Management held 7,400 shares of CG Oncology worth $526K as of Q2 2026.
  • E Fund Management sold 1,379 CG Oncology shares in Q2 2026, an estimated $90.1K.
  • CG Oncology made up 0.01% of E Fund Management's portfolio in Q2 2026, its #254 holding.
  • E Fund Management first reported a position in CG Oncology in Q2 2025 and has held it in 3 quarters since.
  • E Fund Management's CG Oncology position peaked at $594K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.